Search results (150)
« Back to NewsOxford University breakthrough on global COVID-19 vaccine
23 November 2020
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
Oxfordshire Young Scientists of the Year 2020
20 November 2020
This year's Young Scientists of the Year 2020 events for outstanding Year 13 science students in Oxfordshire and Buckinghamshire took place on Wednesday 19 November together with their families and teachers attending via zoom!
Oxford ramps up COVID-19 testing capability
11 November 2020
The University of Oxford has joined forces with Thermo Fisher Scientific, the world leader in serving science, to ramp up the university’s capacity to deliver COVID-19 testing data.
Trials of Oxford coronavirus vaccine begin in Kenya
30 October 2020
Kenya has joined the global efforts in search of an effective vaccine for COVID-19 with the start of a trial evaluating the ChAdOx1 nCoV-2019 Oxford coronavirus vaccine. Following the necessary approvals from regulators, as well as the national ministry of health, and Kilifi county, the first volunteers for the trial have recently received their vaccinations.
NDM New Professors
29 October 2020
The University's latest Recognition of Distinction Exercise has awarded the Nuffield Department of Medicine three new Professors; Elisabeth Ashley - Professor of Tropical Medicine. Stuart Blacksell - Professor of Tropical Microbiology and John B Davis - Professor of Pharmaceutical Discovery.
NDM’s Jenner Institute appoints first Bvlgari Scholars
23 October 2020
Following the announcement in June of a new philanthropic relationship between Bvlgari and the University of Oxford, Bvlgari’s donation in support of DPhil students in vaccine research benefits two exceptional students, appointed as the first cohort of Bvlgari Scholars. The Jenner Institute welcomes students Cameron Bissett and Rebecca Makinson this month for the start of their DPhil courses, after demonstrating remarkable academic potential and merit in the field of vaccine-related immunology.
New partnership with The Alan Turing Institute and Royal Statistical Society to support Joint Biosecurity Centre COVID-19 response
21 October 2020
Prof Chris Holmes, The Alan Turing Institute’s Programme Director of Health and Medical Science, and Professor of Biostatistics at the Nuffield Department of Medicine, said: “The Turing is delighted to be playing a pivotal role in supporting the JBC by working to build an alliance with the RSS and academic experts to provide new insights in the evolving fight against COVID-19. In doing so, we will strengthen knowledge across the wider public health ecosystem."
Understanding the immunity of recovered Covid-19 patients
16 October 2020
Thousands of lives could be saved by measuring the strength of the antibody response in those who have had the virus and how long their immunity may last for. Professor Paul Klenerman and his team at the University of Oxford have partnered with Oxford University Hospitals NHS Foundation Trust (OUH) to test thousands of healthcare workers.
Simon Leedham appointed as Professor of Molecular and Population Genetics
12 October 2020
Congratulations to Simon Leedham BSc PhD QMUL, MB BS London, FRCP, Professor of Gastroenterology and Wellcome Trust Senior Research Fellow in Clinical Science in the Wellcome Trust Centre for Human Genetics, has been appointed to the Professorship of Molecular and Population Genetics in the Wellcome Trust Centre for Human Genetics, Nuffield Department of Medicine. He took up the post on 1 October 2020 and will be a Fellow of Queen's College, Oxford.
Prof Sarah Walker receives OBE
12 October 2020
Prof Walker was recognised for services to academia and the COVID-19 response. Sarah is also the chief investigator and academic lead for the National Covid-19 Infection Survey, a collaboration between the University and the Office for National Statistics (ONS), investigating prevalence and incidence of current and past infections of the virus in the UK.
Comparison of five tests used to detect COVID-19 antibodies shows Siemens and Oxford assays met regulatory targets
28 September 2020
New research shows that, in a head-to-head comparison of five tests used to detect COVID-19 antibodies (known as ‘immunoassays’), an assay manufactured by Siemens and one developed by an academic partnership led by the University of Oxford had the most accurate results. The study is published in The Lancet Infectious Diseases.
Evaluation of LamPORE rapid tests for Covid-19 show high levels of diagnostic sensitivity
25 September 2020
Scientists from the University of Oxford’s Nuffield Department of Medicine have today published their evaluation of LamPORE, a novel diagnostic platform for detecting SARS-CoV-2 RNA. It combines loop-mediated isothermal amplification with nanopore sequencing. This technology has the potential to analyse thousands of samples per day on a single instrument.
Oxford’s OpenABM-Covid19 mathematical model helps to control the coronavirus epidemic
23 September 2020
A team of mathematical modellers and epidemiologists at Oxford University’s Nuffield Department of Medicine release the latest model of a population responding to the coronavirus epidemic. The model - OpenABM-Covid19 - provides public health decision-makers with the ability to review the potential progression and outcome of the coronavirus, including fluctuations in infected individuals, hospitalisations, intensive care unit (ICU) admissions and deaths, and assess the impact of test and trace programmes.
New research shows tracing apps can save lives at all levels of uptake
7 September 2020
The latest research findings from a team of modellers and epidemiologists at Oxford University’s Nuffield Department of Medicine and Google Research suggest digital contact tracing, such as that based on Google and Apple’s Exposure Notification System (ENS), can help to control the epidemic at low levels of app uptake.
Persistent immune memory of COVID-19 found in recovered patient T cells
7 September 2020
Oxford University researchers have found that natural infection with COVID-19 produces a robust T cell response, including inducing T cell ‘memory’ to potentially fight future infections.
Collaboration with Magdalen College outreach to run remote work experience
19 August 2020
Ludwig Oxford's Dr Tammie Bishop organised a week of work experience for fifteen year 12 students in collaboration with the Magdalen Outreach Team. University Research Lecturer Dr Tammie Bishop works in the laboratory led by 2019 Nobel Prize-winning Sir Peter Ratcliffe (Target Discovery Institute & Ludwig Institute for Cancer Research) which conducts research into hypoxia, as well as currently being involved in research into the role of hypoxia in SARS-CoV-2.
Latest version of COVID-19 contact tracing app ready for testing on the Isle of Wight and Newham, London
14 August 2020
The Department of Health & Social Care announced the latest version of the contact tracing app will be tested on the Isle of Wight and with NHS volunteers from this week, and in the London Borough of Newham from next week. The app will enable you to report your symptoms and book a test directly through the app. If you test positive for COVID-19, your close proximity contacts from the last 2 weeks will be notified and advised to isolate to prevent onward spread of the virus.
Dave Stuart awarded The Gabor Medal 2020
4 August 2020
The Royal Society has today announced that it is awarding its Gabor Medal to David Stuart, who is Professor of Structural Biology in the Nuffield Department of Medicine and the Life Sciences Director of the Diamond Light Source, the National Synchrotron at Harwell. Professor Stuart is currently leading a large number of projects relating to the University’s response to COVID19, which include studying the structure of SARS-Cov-2 and a series of anti-viral drug discovery programmes. He is also leading the Oxford research team providing antibody immunity data on the UK population for the Office of National Statistics.
New study reveals Oxford coronavirus vaccine produces strong immune response
22 July 2020
A team of scientists at NDM’s Jenner Institute and The Oxford Vaccine Group has taken the next step towards the discovery of a safe, effective and accessible vaccine against coronavirus. The results of the Phase I/II trial published recently in the scientific journal, The Lancet, indicate no early safety concerns and induces strong immune responses in both parts of the immune system.